GLP-1 and hunger modulate incentive motivation depending on insulin sensitivity in humans.
Glucagon-like peptide-1
Hunger
Insulin sensitivity
Obesity
Regulation of motivational behaviour
Journal
Molecular metabolism
ISSN: 2212-8778
Titre abrégé: Mol Metab
Pays: Germany
ID NLM: 101605730
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
21
10
2020
revised:
22
12
2020
accepted:
08
01
2021
pubmed:
17
1
2021
medline:
26
10
2021
entrez:
16
1
2021
Statut:
ppublish
Résumé
To regulate food intake, our brain constantly integrates external cues, such as the incentive value of a potential food reward, with internal state signals, such as hunger feelings. Incentive motivation refers to the processes that translate an expected reward into the effort spent to obtain the reward; the magnitude and probability of a reward involved in prompting motivated behaviour are encoded by the dopaminergic (DA) midbrain and its mesoaccumbens DA projections. This type of reward circuity is particularly sensitive to the metabolic state signalled by peripheral mediators, such as insulin or glucagon-like peptide 1 (GLP-1). While in rodents the modulatory effect of metabolic state signals on motivated behaviour is well documented, evidence of state-dependent modulation and the role of incentive motivation underlying overeating in humans is lacking. In a randomised, placebo-controlled, crossover design, 21 lean (body mass index [BMI] < 25 kg/m In this report, we demonstrate that incentive motivation increases with hunger in lean humans (F We report a differential effect of hunger on motivation depending on insulin sensitivity. We further revealed the modulatory role of GLP-1 in adaptive, motivated behaviour in humans and its interaction with peripheral insulin sensitivity and hunger. Our results suggest that GLP-1 might restore dysregulated processes of midbrain DA function and hence motivational behaviour in insulin-resistant humans.
Identifiants
pubmed: 33453418
pii: S2212-8778(21)00003-X
doi: 10.1016/j.molmet.2021.101163
pmc: PMC7859312
pii:
doi:
Substances chimiques
Glucagon-Like Peptide-1 Receptor
0
Insulin
0
Liraglutide
839I73S42A
Glucagon-Like Peptide 1
89750-14-1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101163Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier GmbH.. All rights reserved.